-
Product Insights
Coronary Stenosis Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Coronary Stenosis Global Clinical Trials Review, H2, 2020" provides an overview of Coronary Stenosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Coronary Stenosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Pre-Eclampsia Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Pre-Eclampsia Global Clinical Trials Review, H2, 2020" provides an overview of Pre-Eclampsia Clinical trials scenario. This report provides top line data relating to the clinical trials on Pre-Eclampsia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Coronary Artery Disease (CAD) Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Coronary Artery Disease (CAD) Global Clinical Trials Review, H2, 2020" provides an overview of Coronary Artery Disease (CAD) (Ischemic Heart Disease) Clinical trials scenario. This report provides top line data relating to the clinical trials on Coronary Artery Disease (CAD) (Ischemic Heart Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase,...
-
Product Insights
Raynauds Disease Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Raynauds Disease Global Clinical Trials Review, H2, 2020" provides an overview of Raynauds Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Raynauds Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Atrial Flutter Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Atrial Flutter Global Clinical Trials Review, H2, 2020" provides an overview of Atrial Flutter Clinical trials scenario. This report provides top line data relating to the clinical trials on Atrial Flutter. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Tachycardia (Tachyarrhythmias) Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H2, 2020" provides an overview of Tachycardia (Tachyarrhythmias) Clinical trials scenario. This report provides top line data relating to the clinical trials on Tachycardia (Tachyarrhythmias). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Cerebral Infarction (Brain Infarction) Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H2, 2020" provides an overview of Cerebral Infarction (Brain Infarction) Clinical trials scenario. This report provides top line data relating to the clinical trials on Cerebral Infarction (Brain Infarction). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Critical Limb Ischemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
The Critical Limb Ischemia Clinical Trial Analysis research report provides an overview of Critical Limb Ischemia Clinical trials scenario. This report provides top-line data relating to the clinical trials on Critical Limb Ischemia. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. The report also provides prominent...
-
Sector Analysis
Pulmonary Arterial Hypertension - Epidemiology Forecast to 2029
Pulmonary arterial hypertension (PAH) is a rare, progressive disorder characterized by vascular proliferation and remodeling of the small pulmonary arteries (Humbert et al., 2004; Humbert et al., 2010; Simonneau et al., 2004). In PAH, blood vessels in the lungs are narrowed, blocked, or destroyed. The damage slows blood flow through the lungs (Mayo Clinic, 2020). This results in progressively increasing pulmonary vascular resistance, leading to an increase in pulmonary arterial pressure (Humbert et al., 2004, 2010; Simonneau et al., 2004)....
-
Product Insights
Dilated Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2021 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dilated Cardiomyopathy - Drugs in Development, 2021, provides an overview of the Dilated Cardiomyopathy (Cardiovascular) pipeline landscape. Dilated cardiomyopathy (DCM) is a condition in which the heart's ability to pump blood is decreased because the heart's main pumping chamber, the left ventricle, is enlarged and weakened. Symptoms include Fatigue and weakness, Shortness of breath (dyspnea), lightheadedness, dizziness or fainting, persistent cough or wheezing, lack of appetite, sudden weight gain from...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.